Acute ST-elevation myocardial infarction
1Department of Cardiology, Gasthuisberg University Hospital, University of Leuven, Leuven, Belgium. peter.sinnaeve@uz.kuleuven.ac.be
Insights
Acute ST-elevation myocardial infarction (STEMI) is a major killer, often stemming from undiagnosed coronary artery disease. Prompt treatment and guideline adherence are crucial for better outcomes and managing heart failure post-infarction.
Area of Science:
- Cardiology
- Emergency Medicine
- Public Health
Background:
- Acute ST-elevation myocardial infarction (STEMI) is a primary cause of mortality in industrialized nations.
- Many STEMI cases represent the initial manifestation of underlying atherosclerotic coronary artery disease.
- Delayed medical attention due to symptom misinterpretation contributes to poorer patient outcomes.
Purpose of the Study:
- To review the established paradigm of early, complete, and sustained infarct-related artery patency in STEMI management.
- To discuss the impact of aggressive therapies like fibrinolysis and primary PCI on STEMI patient outcomes.
- To highlight challenges in guideline adherence and the growing prevalence of chronic heart failure post-myocardial infarction.
Main Methods:
- Literature review of studies on STEMI management and outcomes.
- Analysis of therapeutic strategies including fibrinolysis and primary percutaneous coronary intervention (PCI).
- Examination of factors influencing patient outcomes, including treatment adherence and the development of chronic heart failure.
Main Results:
- Early, complete, and sustained infarct-related artery patency is a proven beneficial strategy in STEMI.
- Aggressive reperfusion therapies (fibrinolysis, primary PCI) have improved outcomes for many STEMI patients.
- Suboptimal adherence to treatment guidelines and the increasing incidence of chronic heart failure remain significant concerns.
Conclusions:
- Despite advances, suboptimal guideline adherence negatively impacts STEMI patient outcomes.
- Effective management of STEMI requires timely revascularization and consistent adherence to evidence-based treatment protocols.
- The growing population of patients with chronic heart failure post-myocardial infarction necessitates ongoing research and improved care strategies.
Abstract:
Acute ST-elevation myocardial infarction (STEMI) remains the leading cause of death in industrialized countries. For many patients, a myocardial infarction is the first presentation of atherosclerotic coronary artery disease. This often results in delays in obtaining medical attention and subsequently poorer outcome, certainly because symptoms are often misinterpreted. Furthermore, a large proportion of STEMI patients die from lethal arrhythmias even before reaching medical facilities. Numerous studies during the past decades have firmly established the paradigm of achieving early, complete and sustained infarct-related artery patency. Because of a more aggressive therapy and rapid revascularization using either fibrinolysis or primary PCI, many patients do remarkably well after STEMI. Unfortunately, adherence to treatment guidelines is often suboptimal, leading to less favourable outcome. Also, more efficient care for patients with myocardial infarction has led to a rapidly growing population of patients with chronic heart failure.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:27Myocarditis II: Clinical Features and Diagnostic Tests